Healthcare Analytics, Population Health Management, Healthcare Big Data

Precision Medicine News

Precision Medicine Approach Reduces Heart Failure Mortality by 50%

November 15, 2018 - A precision medicine approach cut mortality rates for high-risk heart failure patients by 48 percent, and 30-day hospital readmissions by 25 percent, according to new research from the Intermountain Medical Center Heart Institute. Researchers applied a team-based care method guided by personalized patient risk scores across eight of Intermountain Healthcare’s largest hospitals....


Articles

Harvard Medical School Gets $200M for Precision Medicine Research

by

Harvard Medical School (HMS) has received a $200 million grant that will help accelerate precision medicine research, advance artificial intelligence, and increase scientific collaboration. The gift from the Blavatnik Family Foundation,...

Effective Precision Medicine Requires Moving Beyond the EHR

by

Electronic health records are not enough to support truly effective precision medicine at the point of care, said providers participating in a survey from KLAS research, but more targeted health IT tools are producing high rates of...

FDA Clears 23andMe Genetic Test for Medication Metabolism Variants

by

Consumers will now be able to purchase an over-the-counter test to screen for genetic variants that may influence medication metabolism, the FDA has announced. The direct-to-consumer test from 23andMe is a first for the American market,...

Duke Engineering Establishes Big Data, Precision Medicine Center

by

Duke University Pratt School of Engineering has established a new big data analytics center that will support global research to advance precision medicine. Launched last month, the Sherry and John Woo Center for Big Data and Precision...

Consumers Curious About AI, Genetic Testing for Precision Medicine

by

Healthcare consumers are cautious but optimistic that emerging strategies like artificial intelligence and advanced genetic testing can lead to better care for cancer, according to a new survey from McKesson and Ipsos. The poll of more...

Amazon, APIs to Support Cloud Informatics Platform for Life Sciences

by

Amazon Web Services (AWS), Accenture, and Merck have announced a collaboration to create a cloud-based informatics research platform to support advances in the life sciences. The project will accelerate drug development by improving...

$21M Grant to “All of Us” Orgs Will Support Precision Medicine Research

by

The HHS Health Resources and Services Administration (HRSA) has awarded $21 million to 46 community health centers to support their participation in NIH’s All of Us precision medicine research program. The grant will allow community...

Machine Learning, Genomics Predict Risk of Aortic Aneurysm

by

The combination of machine learning tools and genomic data can help predict the risk of abdominal aortic aneurysm (AAA), one of the most frequently fatal heart conditions - and one that is most often diagnosed only after a patient’s...

Precision Medicine Researchers Identify New Alzheimer’s Genes

by

Researchers from Boston University School of Medicine, in collaboration with scientists from the Alzheimer’s Disease Sequencing Project (ADSP), have discovered new genes that could contribute to the onset of Alzheimer’s...

Georgetown Offers Brain Cancer Data for Precision Medicine Research

by

Georgetown Lombardi Comprehensive Cancer Center will now make its collection of brain cancer data freely available to precision medicine researchers worldwide. The dataset, called the REpository for Molecular BRAin Neoplasia DaTa...

How to Bring Precision Medicine into Routine Clinical Care

by

Precision medicine has taken the healthcare industry by storm in recent years, offering the promise of more individualized treatments, improved patient outcomes, and a deeper understanding of genetic conditions and rare...

VA, IBM Watson Extend AI, Genomics Partnership for Cancer Care

by

The Department of Veteran Affairs (VA) and IBM Watson Health have announced an extension of their partnership to bring artificial intelligence and genomic analytics to cancer care. The VA’s precision oncology program primarily...

UPMC, UPitt Launch Genome Sequencing Center for Medical Research

by

The University of Pittsburgh Medical Center (UPMC) and the University of Pittsburgh have announced the creation of the UPMC Genome Center, an advanced genome sequencing facility that will enhance clinical diagnostics and support precision...

NCI Studies Link Dozens of Genetic Variants to Cancer

by

The discovery of genetic variants that are associated with cancer development could assist providers with identifying high-risk patients and crafting precision medicine therapies for oncology, according to new research funded by the...

Clinical Decision Support from Dana-Farber Powers Cancer Care

by

Experts at Dana-Farber Cancer Institute are partnering with Royal Philips to provide improved clinical decision support for cancer care. The incredibly complex nature of cancer, coupled with its many available treatment options, has long...

FDA: Drug Development Transparency Key for Precision Medicine

by

New guidance from the FDA urges drug development stakeholders to be transparent with their data as a way to maintain high quality and foster patient-centered precision medicine.   Innovative, personalized treatments are being...

WVU Genetic Test to Improve Lung Cancer Treatment

by

Researchers at the West Virginia University (WVU) Cancer Institute are developing a genetic test that will improve treatment for patients with lung cancer and help physicians determine which patients will benefit from chemotherapy and...

NIH Precision Medicine Clinical Trial Releases New Findings

by

The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has released results from several sub-studies that could bring targeted treatments to patients...

Broader Availability of Genetic Testing a Boon for Precision Care

by

Precision medicine is quickly moving out of the realm of science fiction and into the everyday routines of oncologists, neurologists, and other providers treating patients who may have had little hope just a few short years ago. While the...

X

Join 25,000 of your peers

Register for free to get access to all our articles, webcasts, white papers and exclusive interviews.

Our privacy policy


no, thanks

Continue to site...